Each year, OACA Faculty Research Development grants are awarded to support new or expanding interdisciplinary research that addresses significant clinical issues, is innovative, and has a high potential for return on investment.
In 2021, the grant program received 27 applications. A group of 44 reviewers from across the University worked diligently to identify the grant recipients who were awarded up to $200,000 in funds.
The 2021 recipients are:
Paula Ludewig, PhD, PT, professor, Medical School; and Victor Barocas, PhD, professor, College of Science and Engineering
"Subject-Specific Rotator Cuff Treatment Planning"
Isha Mutreja, PhD, research assistant professor, School of Dentistry; and Elizabeth Bradley, PhD, assistant professor, Medical School
"Designing an injectable system using osteoclast exosomes for bone regeneration"
Hongbo Pang, PhD, assistant professor, College of Pharmacy; and Tanya Freedman, PhD, assistant professor, Medical School
"Peptide-targeted delivery to improve the efficacy and safety of corticosteroid drugs against rheumatoid arthritis"
Ned Patterson, DVM, PhD, professor, College of Veterinary Medicine; and James Cloyd, PharmD, professor, College of Pharmacy
"Allopregnanolone, a Novel Neurosteroid Drug, for Treatment of Status Epilepticus"
Valerie Pierre, PhD, associate professor, College of Science and Engineering; and Peter Dosa, PhD, research associate professor, College of Pharmacy
"Orally Bioavailable Iron Chelators for the Treatment of Iron Overload"
Ian Ramsay, PhD, assistant professor, Medical School; and Dereck Salisbury, PhD, assistant professor, School of Nursing
"Sprint interval training to target brain oscillations in first-episode psychosis"
Patrick Rothwell, PhD, assistant professor, Medical School; and Swati More, PhD, associate professor, College of Pharmacy
“Control of Endogenous Opioid Signaling by Domain-Selective Inhibition of Angiotensin Converting Enzyme”